We just published a list of 10 startups innovating in the growing marijuana market. Here is another one: Jacana is a new UK-based startup that produces certified medical cannabis to provide natural relief for chronic pain and suffering – a problem that affects half of all UK adults. With an ageing population, the demand for alternative pain relief options is increasing, and the medical cannabis market is expected to be worth $100 million by 2025.
The startup has completed the first-ever international export of Jamaican medical cannabis flower, securing multiple international licenses and permits, and has furthermore raised €22 million to cultivate, develop and distribute certified medical cannabis solutions. This comes on the heels of the UK’s legalisation of medical cannabis in November 2018.
The investment will fuel international expansion and build on Jacana’s existing presence in Europe, North America and the Caribbean. The cannabis is currently being grown at Jacana’s 100 acre farm in St Ann, Jamaica, which has a unique microclimate and latitude create perfect conditions for cultivation.
“Whether caused by illness or injury, chronic pain is a problem that affects the global population,” said Alexandra Chong, CEO of Jacana. “People are looking for safe, natural solutions, and care more about what they’re putting in their bodies than ever before.”
“We believe that nature has the best answers. Jacana’s mission is to provide natural medicine that people can trust, enabling them to live full and meaningful lives by improving their wellbeing, their health, and their happiness.”